This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Two Westlake Village biotech companies released new data from product trials, spurring stock moves and presaging capital raises to fund further research and development. Analysts remained optimistic on Sienna Biopharmaceuticals despite an 18 percent drop in the stock June 10, after the company released results from clinical trials of its psoriasis product. Despite the Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
By Stephen Nellis / Friday, January 17th, 2014 / Technology, Top Stories / Comments Off on New capital injection brings Suneva Medical total to $70.5M
Suneva Medical, a San Diego aesthetics company with executive offices in Santa Barbara, has raised $35 million in debt and equity financing, bringing its total funding to $70.5 million over the past two years.
By Stephen Nellis / Friday, January 17th, 2014 / Technology, Top Stories / Comments Off on Round 2: Atara raises $13.5M as T.O. biotech boom takes hold
Thousand Oaks-based Atara Biotherapeutics has brought on more investors to its second financing round, bringing the total raised to $52 million.
Santa Barbara-based inbound call technology firm Invoca has raised $20 million from Accel Partners, bringing the company’s funds raised to date to $30.8 million.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.